Répertoire des membres

Dr Jordan Feld

Nominated Principal Investigator

Titre professionel : R. Phelan Chair in Translational Liver Disease Research; Director, Toronto Centre for Liver Disease; Section Head of Hepatology, Toronto General Hospital; Professor of Medicine, University of Toronto; Co-Director, CanHepC

Province / Territoire : Ontario

Primary Affiliation : University Health Network

Domaine de recherche :

Immunology

CIHR pillar:

Recherche clinique

Courriel : jordan.feld@uhn.ca

Profil institutionel

Liste des publications récentes

(en_CA) Estimating the annual number of hepatitis C virus infections through vertical transmission at country, regional, and global levels: a data synthesis study

23-07-2025 Voir la publication

(en_CA) Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario

05-03-2024 Voir la publication

(en_CA) Real-world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada

22-02-2024 Voir la publication

(en_CA) Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study

21-10-2023 Voir la publication

(en_CA) Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC Analysis

09-01-2025 Voir la publication

(en_CA) Mixed-Genotype HCV Direct Acting Antiviral Outcomes: a CANUHC Analysis

05-08-2024 Voir la publication

(en_CA) Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada

19-04-2025 Voir la publication

(en_CA) Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries